Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 439
Selected: 0
NCT IDTitle
NCT06158139Autologous CAR-T Cells Targeting B7-H3 in PDAC
NCT03694834Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer
NCT02246907Exercise and Quality of Life in Leukemia Patients
NCT04350788Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program
NCT01573702Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
NCT03264131BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
NCT00280150Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT05377749The Families Addressing Cancer Together Intervention for Parents With Cancer
NCT05985538Impact of E-Cigarette Prevention Messages on Adolescents
NCT07078838Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
NCT01776138Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer
NCT00002984Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus
NCT02008058Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT04266730Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab
NCT03446157Palbociclib and Cetuximab in Metastatic Colorectal Cancer
NCT07276880Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
NCT04076696Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis
NCT00312637Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT07068477Adaptation of a Values Assessment Tool
NCT05630131ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT05978557Brain Slice Explants to Predict Drug Response in Brain Tumors
NCT05472792Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
NCT07829146Feasibility Pilot of AYA-PARTNER
NCT05414097Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa
NCT07630168Effects of Infusion Timing on Treatment Response in Solid Tumors
NCT03951090Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients
NCT05574478Metastatic Breast Cancer-Specific Prognostic Tool
NCT06878547VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
NCT07304063Overcoming Barriers to Uptake of Cascade Screening
NCT03161821Circulating Tumor Cells in Solid Tumors
NCT01726738LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations
NCT03339206Enhancing Source Credibility in Tobacco Regulatory Communications
NCT03089606Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
NCT07639242Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC
NCT05736718Engaging Clinical Champions to Improve HPV Vaccination
NCT02684461Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
NCT04134325Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
NCT06546618Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking
NCT02798224A Patient Portal Tool, E-assist, for Supporting CRC Screening
NCT07526597Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
NCT01789983Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy
NCT00380029Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
NCT06096623The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment
NCT07867002Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer
NCT02844400Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation
NCT06702592Virtual Testis Cancer Lay Support and Survivorship Aim 2
NCT01845519Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors
NCT01467310Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
NCT00099008Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
NCT02276560Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC